Valtorta et al. in 2015 devised IHC/FISH criteria for HER2/neu overexpression in CRC and identified patients for enrolment in the phase II HER2 amplification for colorectal cancer enhanced stratification (HERACLES) trial. The gene discussed is ERBB2; the disease is colorectal cancer.